Immunotherapy

Immunotherapy Breakthrough: New Hope for Colorectal Cancer Treatment!

by

Boston, MA – The rising incidence of bowel cancer has raised concerns among healthcare professionals and researchers. The development and exploration of immunotherapy drugs have shown promise in addressing this growing health issue. These innovative treatments aim to enhance the body’s immune response to cancer cells, potentially improving patient outcomes. Studies have shown that advanced colorectal cancer patients may benefit from new combinations of immunotherapy drugs. These therapies have the potential to be more effective …

Read more

Game Changing FDA Approval for Cancer Immunotherapy Lifileucel After 40 Years: Amtagvi Receives Accelerated FDA Approval for Advanced Melanoma

by

LOS ANGELES, California – After nearly four decades since its inception, the first TIL therapy has received accelerated approval from the Food and Drug Administration for advanced melanoma. This immunotherapy, which harvests cancer-fighting immune cells from the patient’s own body, is called Amtagvi or lifileucel from Iovance, and is the first cell therapy approved for a solid tumor. Allison Betof Warner, a cell therapy researcher and physician at Stanford University, expressed her excitement and gratification, …

Read more